Uncategorized Archives - Page 225 of 232

WednesdayMar 29, 2017 8:30 am

Marijuana Legalization Could Encourage Widespread Economic Benefits

There are a number of advantages to society and the public safety in regulating marijuana, but economic arguments also favor its legalization. The benefits include increased tax revenues, job creation, and reduced law enforcement costs. However, to legalize and regulate marijuana requires an ecosystem of support services like those provided by SinglePoint, Inc. (SING) (SING Profile), American Cannabis Company (AMMJ), Kush Bottles, Inc. (KSHB), mCig, Inc. (MCIG) and Terra Tech Corp. (TRTC). As a job-creating engine, the industry will be a super powerful diesel. Reporting on recently released data from New Frontier Data, Forbes(1) relates industry analyst projections that “by…

TuesdayMar 28, 2017 12:13 pm

India Globalization Capital, Inc. (NYSE: IGC) Aims to Become a Leading Provider of Cannabis-Based Combination Therapies

India Globalization Capital, Inc. (NYSE MKT: IGC) has set a long-term goal for itself in the U.S. of becoming a leading provider of cannabis-based pharmaceutical and nutraceutical products. This is a transition away from its earlier short-term strategy, including the sale of electronics and development of a hotel site in Malaysia. To this end, the company has jettisoned its electronics business. IGC is now fully focused on building a portfolio of patents and starting clinical and pre-clinical trials for a series of pain-reducing and other cannabis-based therapies. These therapies are designed to treat neuropathic pain, seizures, Parkinson’s, anorexia/cachexia, Alzheimer’s, and…

ThursdayMar 23, 2017 3:37 pm

ChineseInvestors.com, Inc. (CIIX) Set to Open California Retail Store, Launches XiBiDi Biotechnology in China

ChineseInvestors.com, Inc. (OTCQB: CIIX) is planning to open a retail store in San Gabriel, California, the same city in which the company is headquartered. The company also recently announced its new online cannabidiol (CBD) oil retail store would be operated by its newly-launched XiBiDi Biotechnology Co., Ltd subsidiary, which is headquartered in the Pudong Free-Trade Area of Shanghai, China. XiBiDi Biotechnology will focus on the online and offline sales of health products, including a range of hemp-derived food and beverages. In a news release, Warren Wang, founder and CEO of CIIX, said he was delighted with the registration and establishment…

ThursdayMar 23, 2017 9:13 am

Singlepoint, Inc. (SING) CEO Greg Lambrecht Reveals High Points of Convectium Acquisition

Singlepoint, Inc. (OTC: SING), specializing in small- to mid-sized company acquisitions, recently began funding Convectium, an organization that sells equipment in the cannabis industry. There should be “more funding on the way,” according to Singlepoint CEO Greg Lambrecht, who discussed the acquisition in a recent episode of MoneyTV with Donald Baillargeon. Convectium sells machines that fill vials with oil, and it created a unique system for filling/packaging vape cartridges and disposable vape pens. These systems, and point of sale equipment, are sold at various trade shows, according to Lambrecht. In the phone interview, Lambrecht also revealed that Singlepoint is looking…

WednesdayMar 22, 2017 8:30 am

Mixed Marijuana Messages from Trump Administration Make Diversification Imperative

Deciphering marijuana policy under the Trump Administration can be difficult, given differing statements by White House officials. Federal laws are at odds with a number of states that have legalized marijuana for medical and/or recreational use, and businesses like SinglePoint, Inc. (SING) (SING Profile), Corbus Pharmaceuticals Holdings, Inc. (CRBP), Medical Marijuana, Inc. (MJNA), Cannabis Science, Inc. (CBIS) and ChineseInvestors.com, Inc. (CIIX) (CIIX Profile) operate in a manner that hedges them against certain risks of federal prohibition. On the campaign trail, then-candidate Donald Trump said of medical marijuana on Fox News: “I'm in favor of it a hundred percent.” With regard…

TuesdayMar 21, 2017 3:03 pm

India Globalization Capital, Inc. (NYSE: IGC) Pioneering New Phytocannabinoid Products

Although legal in 28 states for medicinal use, cannabis is still considered a dangerous substance in much of the country. However, many experts now believe that cannabis is a safe alternative to pharmaceuticals for relieving symptoms related to multiple illnesses. Scientific research shows that phytocannabinoids, cannabinoids that occur naturally in the cannabis plant, are effective at relieving convulsions, seizures, anxiety, nausea, and inflammation. From fighting glaucoma to controlling epileptic seizures and easing pain, scientific research has repeatedly shown the efficacy of medicinal marijuana. Due to government misclassification of cannabis as a Schedule 1 drug, there has been only marginal progress…

ThursdayMar 16, 2017 1:58 pm

ChineseInvestors.com (CIIX) Helping Treat Patients with Amyotrophic Lateral Sclerosis

Late February, a study was released (http://nnw.fm/R2CEp) reviewing evidence that supports the use of cannabinoids to treat Amyotrophic Lateral Sclerosis (ALS), a progressive neurodegenerative disease that affects nerve cells in the brain and the spinal cord. Also known as Lou Gehrig’s disease, ALS is a fatal illness that attacks the nerve cells that control voluntary muscles such as those in the face, arms, legs, and others. Currently, ALS is treated with riluzole, a drug that controls neuronal signaling, but this drug does not cure the disease and can only slightly increase the chance of survival. With more effective therapeutic options…

ThursdayMar 16, 2017 1:15 pm

InMed Pharmaceuticals (IMLFF) Lead Product Candidate Targeting Rare, Incurable Skin Disease

With a prevalence of 20 per million newborns in the United States, and an estimated 500,000 patients worldwide, epidermolysis bullosa is a group of rare inherited skin diseases that range in severity from mild to lethal and have no currently approved or known cure or treatment. The condition was brought to the public attention in the early 2000s, and, since then, efforts to find a cure have not born fruit, with most research and development focusing instead on addressing the symptoms, such as reducing blistering and swelling and preventing wounds and pain. However, a new product currently in development by…

ThursdayMar 16, 2017 8:30 am

Unique Cannabis-Pharma Companies Trailblazing the Medical Cannabis Industry

The cannabis industry has swiftly turned into a multi-billion dollar opportunity. In the United States, this market’s massive growth potential is being recognized as new states legalize marijuana for medical or recreational use. Industry experts forecast the U.S. cannabis market rounding $7 billion in 2016, while the annual sale of state-legal cannabis products is forecast to exceed $20 billion by 2020. Within this flourishing market, cannabis-pharma companies like India Globalization Capital (IGC) (IGC Profile), Zynerba Pharmaceuticals, Inc. (ZYNE), OWC Pharmaceutical Research Corp. (OWCP), Insys Therapeutics, Inc. (INSY) and GW Pharmaceuticals plc (GWPH) are carving lanes of unprecedented opportunities in the…

WednesdayMar 15, 2017 8:30 am

“No-Touch” Approach Reduces Risk as Public Companies Tap Explosive Growth of Cannabis Industry

The marijuana industry is the new investing frontier. As a result of last November’s elections, eight states and the District of Columbia now allow the recreational use of marijuana, while another 28 states permit its use for medicinal purposes. In what has been touted as the fastest-growing industry in the U.S., investment opportunities in the cannabis space appear boundless. Companies like Singlepoint, Inc. (SING) (SING Profile), American Cannabis Company Inc. (AMMJ), General Cannabis Corp. (CANN), The Scotts Miracle-Gro Company (SMG) and Terra Tech Corp. (TRTC) are all employing a “no-touch” approach to their cannabis business models. By creating business models…

News and publishing service for CBD related companies

Contact us: 512.354.7000

Category: Uncategorized